Top View
- 684Fm.3 Iloprost Infusion Protocol
- 1628.Full-Text.Pdf
- First Inhaled Treatment Approved for PAH
- Management of Antithrombotic Drugs in Association with Endoscopic
- Infusion of Iloprost, a Prostacyclin Analogue, for Treatment of Raynaud's Phenomenon in Systemic Sclerosis
- Iloprost Suppresses Connective Tissue Growth Factor Production in Fibroblasts and in the Skin of Scleroderma Patients
- Product Information
- Heparin-Induced Thrombocytopenia and Cardiac Surgery Jerrold H
- Reproductive Health Guideline Appendix 3 – Search Strategies
- Profile Profile Uses and Administration Adverse Effects And
- The Biology of Prostaglandins and Their Role As a Target for Allergic Airway Disease Therapy
- PDF (Guidelines for ATC Classification and DDD Assignment)
- Search Strategy Systematic Review of Effect of Statins and Antiplatelets On
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Project SCYLLA
- Systemic Glucocorticoids in the Treatment of COVID-19 and Risks of Adverse Outcomes in COVID-19 Patients in the Primary and Secondary Care Setting
- Clinical Policy: Iloprost (Ventavis) Reference Number: CP.PHAR.193 Effective Date: 03/16 Coding Implications Last Review Date: 03/17 Revision Log
- Ventavis, INN-Iloprost
- Pharmacological Interventions for the Prevention of Fetal Growth Restriction: Protocol for a Systematic Review and Network Meta-Analysis
- Short-Term Intravenous Iloprost for Treatment of Reperfusion Lung
- Repurposing Drugs for COVID-19 Based on Transcriptional Response of Host Cells to SARS-Cov-2
- Supplementary Material 1. String for MEDLINE Search. 1
- New Zealand Data Sheet
- Pharmaceutical Compositions Comprising Prasugrel And
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Ventavis Data Sheet
- Current Therapeutic Options in Unstable Angina
- Beraprost (Beraprost-314D) on Pulmonary Vascular Tone, IP Receptors and Human Smooth Muscle Proliferation in Pulmonary Hypertension
- Prostanoid Therapy for Pulmonary Arterial Hypertension David B
- Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
- General Agreement on Tariffs Andtrade
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Anticoagulation During Cardiopulmonary Bypass
- Biotechnology Corticosteroids & Hormones Synthesis Prostaglandins
- Selective Prostacyclin Receptor Agonist Selexipag, in Contrast to Prostacyclin Analogs, Does Not Evoke Paradoxical Vasoconstriction of the Rat Femoral Artery
- Iloprost (Ventavis®)
- Ventavis® (Iloprost) Inhalation Solution RX Only
- Iloprost 10 Microgram/Ml Nebuliser Solution
- The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model Lori Dwyer-Nield1, Gregory A
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Effects of Prostaglandin Analogue Iloprost Treatment on Distant Organ Damage Following Ovarian Ischemia/Reperfusion Injury in Rats: an Experimental Study
- Ventavis) Reference Number: CP.PHAR.193 Effective Date: 03.16 Last Review Date: 02.20 Coding Implications Line of Business: Commercial, HIM, Medicaid Revision Log
- Pulmonary Arterial Hypertension
- Adverse Events of Prostacyclin Mimetics in Pulmonary Arterial Hypertension: a Systematic Review and Meta-Analysis
- (12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
- Iloprost & Treprostinil Medical Review Documentation Checklist
- Iloprost Monograph
- Product List 2020 BIOTECH and FERMENTATION PROSTAGLANDINS CORTICOSTEROIDS & HORMONES SYNTHESIS FRANCOPIA Product Name Business Unit Therapeutic Class ATC4 Page